Back to search

Maavrx Ltd

10659971

active
Private Limited Company
Companies House
Health Score
66 / 100

Some Concerns

30/30
Filing
0/30
Financial
36/40
Risk
  • Negative net worth (-10)
  • Current liabilities exceed current assets (-10)
  • 2 outstanding charges (-4)

Details

C/O CMB PARTNERSHIP LIMITED 7 WEY COURT, GUILDFORD, GU1 4QU
Incorporated 08/03/2017

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Michael Mcdonald

director · Since 08/03/2017

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 73

Also on 1 other board

Mr Zuie-Chin Huang

director · Since 08/01/2021

MERCHANT

CHINESE · CHINA · Age 61

Mrs Chrystyna Bedrij Stecyk

director · Since 08/01/2021

FINANCIAL ADVISER

AMERICAN · UNITED STATES · Age 64

Persons with Significant Control

Michael Mcdonald

75–100% shares
75–100% votes
Appoint directors

British · England · Age 73

C/O Cmb Partnership Limited, 7 Wey Court, Guildford, GU1 4QU

Notified 08/03/2017

Charges2 outstanding

Charge
outstanding

HEALING GENES LLC · PANACEA VENTURE HEALTHCARE FUND I, L.P.

Created 05/11/2020Registered 17/11/2020
Charge
outstanding

HEALING GENES LLC · PANACEA VENTURE HEALTHCARE FUND I, L.P.

Created 05/11/2020Registered 17/11/2020

CompanyRankvs 3093+ SIC 72110 peers
24

Financial strength3th percentile among SIC peers · 1/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 0.72× · 6/20
Longevity9 years trading (max 15) · 9/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
3093Maavrx Ltd
30
How is this score calculated?
Financial strength1/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity6/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity9/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2025

Net Worth

-£1.1M

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

-£21k

Working capital

Current Assets

£54k

Current Liabilities

£75k

0avg. employees

Balance Sheet

Assets less current liabilities-£20k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20250.72-£214k
2024168.23-£209k
2023169.63-£173k
2022297.86-£416k
20216.67+£8k
20200.21-£51k
20190.36—

Derived from filed accounts. Not audited figures.